GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Biotage AB (OTCPK:BITGF) » Definitions » Receivables Turnover

Biotage AB (Biotage AB) Receivables Turnover : 1.58 (As of Mar. 2024)


View and export this data going back to 2010. Start your Free Trial

What is Biotage AB Receivables Turnover?

The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. Biotage AB's Revenue for the three months ended in Mar. 2024 was $46.1 Mil. Biotage AB's average Accounts Receivable for the three months ended in Mar. 2024 was $29.1 Mil. Hence, Biotage AB's Receivables Turnover for the three months ended in Mar. 2024 was 1.58.


Biotage AB Receivables Turnover Historical Data

The historical data trend for Biotage AB's Receivables Turnover can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biotage AB Receivables Turnover Chart

Biotage AB Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Receivables Turnover
Get a 7-Day Free Trial Premium Member Only Premium Member Only 6.11 5.91 6.30 7.31 6.88

Biotage AB Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Receivables Turnover Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.59 1.51 1.51 2.22 1.58

Competitive Comparison of Biotage AB's Receivables Turnover

For the Medical Instruments & Supplies subindustry, Biotage AB's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Biotage AB's Receivables Turnover Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Biotage AB's Receivables Turnover distribution charts can be found below:

* The bar in red indicates where Biotage AB's Receivables Turnover falls into.



Biotage AB Receivables Turnover Calculation

Receivables Turnover measures the number of times a company collects its average accounts receivable balance.

Biotage AB's Receivables Turnover for the fiscal year that ended in Dec. 2023 is calculated as

Receivables Turnover (A: Dec. 2023 )
=Revenue / Average Total Inventories
=Revenue (A: Dec. 2023 ) / ((Accounts Receivable (A: Dec. 2022 ) + Accounts Receivable (A: Dec. 2023 )) / count )
=181.524 / ((21.488 + 31.294) / 2 )
=181.524 / 26.391
=6.88

Biotage AB's Receivables Turnover for the quarter that ended in Mar. 2024 is calculated as

Receivables Turnover (Q: Mar. 2024 )
=Revenue / Average Total Inventories
=Revenue (Q: Mar. 2024 ) / ((Accounts Receivable (Q: Dec. 2023 ) + Accounts Receivable (Q: Mar. 2024 )) / count )
=46.104 / ((31.294 + 26.894) / 2 )
=46.104 / 29.094
=1.58

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Biotage AB  (OTCPK:BITGF) Receivables Turnover Explanation

An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.


Biotage AB Receivables Turnover Related Terms

Thank you for viewing the detailed overview of Biotage AB's Receivables Turnover provided by GuruFocus.com. Please click on the following links to see related term pages.


Biotage AB (Biotage AB) Business Description

Traded in Other Exchanges
Address
Vimpelgatan 5, Box 8, Uppsala, SWE, 751 03
Biotage AB provides separation technology and solutions for analytical and organic chemistry from research to commercial analytical laboratories and industrial applications. Its customers span a broad range of market segments including pharmaceutical, biotech, diagnostic, contract research, and contract manufacturers as well as clinical, forensic, and academic laboratories in addition to organizations focused on food safety, clean water, and environmental sustainability. It serves three geographic markets: The Americas, APAC (Asia-Pacific,) and EMEA (Europe, Middle East & Africa). The company's product areas include Small Molecules & Synthetic Therapeutics, Biologics & Advanced Therapeutics, Scale-Up, Diagnostics, Analytical Testing, and Water & Environmental Testing.

Biotage AB (Biotage AB) Headlines

From GuruFocus

Notice of Annual General Meeting in Biotage AB (publ)

By PRNewswire PRNewswire 04-28-2020

Biotage AB (publ) Interim Report January - March 2020

By PRNewswire PRNewswire 04-28-2020

Berenberg Bank is now covering Biotage AB (publ) (BIOT)

By PRNewswire PRNewswire 06-29-2021

Biotage AB (publ) publishes new Financial Goals

By PRNewswire PRNewswire 03-14-2022

Biotage AB (publ) appoints new CFO

By PRNewswire PRNewswire 07-01-2021

New capacity helps eliminate bottleneck for COVID-19 vaccines

By PRNewswire PRNewswire 08-16-2021

Biotage - change in number of shares and votes

By PRNewswire PRNewswire 08-31-2020

Biotage moves to the large cap segment

By PRNewswire PRNewswire 01-03-2022